Full Color.png
Pyxis Reports Financial Results for the Third Quarter of 2021 and Provides Business Update
November 15, 2021 07:15 ET | Pyxis Oncology
CAMBRIDGE, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a preclinical oncology company focused on developing next-generation therapeutics for difficult to treat...
Full Color.png
Pyxis Oncology to Present at the Jefferies London Healthcare Conference
November 10, 2021 08:00 ET | Pyxis Oncology
CAMBRIDGE, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), today announced that management will present at and host one-on-one investor meetings during the virtual...
Full Color.png
Pyxis Announces Pricing of Upsized Initial Public Offering
October 07, 2021 22:24 ET | Pyxis Oncology
CAMBRIDGE, Mass., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target...
Full Color.png
Pyxis Oncology Appoints Jay M. Feingold, M.D., Ph.D., as Chief Medical Officer
September 14, 2021 08:00 ET | Pyxis Oncology
CAMBRIDGE, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Pyxis Oncology ("Pyxis" or the “Company”) today announced the appointment of Jay M. Feingold, M.D., Ph.D., as Chief Medical Officer. “Jay’s...
Full Color.png
Pyxis Oncology Strengthens Board of Directors
September 08, 2021 08:00 ET | Pyxis Oncology
CAMBRIDGE, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Pyxis Oncology ("Pyxis" or the “Company”) today announced the appointments of Freda Lewis-Hall, M.D., Thomas Civik, Darren Cline, and Mark Chin...
Full Color.png
Pyxis Oncology Appoints Pamela Yanchik Connealy as Chief Financial Officer
August 31, 2021 08:00 ET | Pyxis Oncology
CAMBRIDGE, Mass., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Pyxis Oncology ("Pyxis" or the “Company”) today announced the recent appointment of Pamela Yanchik Connealy, M.B.A., as its Chief Financial...
Full Color.png
Pyxis Oncology Strengthens Leadership Team with Executive and Scientific Advisory Board Appointments
June 08, 2021 08:00 ET | Pyxis Oncology
– Steve Monks, Ph.D., appointed as Chief Technical Officer, brings 20+ years in drug development and CMC, Quality, and Regulatory operations – – Ritu Shah, PMP, appointed as Chief Operating Officer,...
Full Color.png
Alloy Therapeutics and Pyxis Oncology Form Kyma Therapeutics to Develop Novel Immune-Modulating Antibodies for Cancer and Autoimmune Diseases
May 25, 2021 08:00 ET | Pyxis Oncology
LEXINGTON, Mass. and CAMBRIDGE, Mass., May 25, 2021 (GLOBE NEWSWIRE) -- Alloy Therapeutics (“Alloy”) and Pyxis Oncology ("Pyxis") today announced the formation of a joint venture named Kyma...
Full Color.png
Pyxis Oncology Presents Preclinical Data and Details on Antibody-Drug Conjugate Candidates Supporting Therapeutic Potential
April 27, 2021 08:00 ET | Pyxis Oncology
CAMBRIDGE, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- Pyxis Oncology ("Pyxis" or the "Company") today announced the targets of its three antibody-drug conjugate (ADC) candidates along with additional...
Full Color.png
Pyxis Oncology Hosting Key Opinion Webinar on Antibody-Drug Conjugates
April 19, 2021 09:03 ET | Pyxis Oncology
CAMBRIDGE, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Pyxis Oncology ("Pyxis" or the "Company") today announced that it will host a key opinion leader (KOL) webinar on antibody-drug conjugates on...